The present invention relates to specific complexes comprising heavy metal ions having an atomic number of 23 or higher and 83 or lower (in particular Ag.sup.1+, Ba.sup.2+, Pb.sup.2+, Gd.sup.3+ and Bi.sup.3+) and one or more hematein ligand(s). In particular, the invention relates to the use of the complexes as ex vivo contrast agents for a computed tomography scanning of a biological sample. Moreover, the invention relates to specific ex vivo methods for investigating a biological sample by means of computed tomography scanning methods, wherein the method comprises staining the biological sample with a solution comprising one or more of the complex(es); or wherein the method comprises staining the biological sample with a staining solution comprising hematein, and separately contacting the biological sample with one or more staining solution(s) comprising one or more heavy metal ions having an atomic number of 23 or higher and 83 or lower (in particular Ag.sup.1+, Ba.sup.2+, Pb.sup.2+, Gd.sup.3+ and Bi.sup.3+).

The present invention relates to specific complexes comprising heavy metal ions having an atomic number of 23 or higher and 83 or lower (in particular Ag.sup.1+, Ba.sup.2+, Pb.sup.2+, Gd.sup.3+ and Bi.sup.3+) and one or more hematein ligand(s). In particular, the invention relates to the use of the complexes as ex vivo contrast agents for a computed tomography scanning of a biological sample. Moreover, the invention relates to specific ex vivo methods for investigating a biological sample by means of computed tomography scanning methods, wherein the method comprises staining the biological sample with a solution comprising one or more of the complex(es); or wherein the method comprises staining the biological sample with a staining solution comprising hematein, and separately contacting the biological sample with one or more staining solution(s) comprising one or more heavy metal ions having an atomic number of 23 or higher and 83 or lower (in particular Ag.sup.1+, Ba.sup.2+, Pb.sup.2+, Gd.sup.3+ and Bi.sup.3+).

Subject matter of the invention are lead-free initiating agents or initiating agent mixtures and initiating and igniting compositions which contain the lead-free initiating agents or initiating agent mixtures.

Subject matter of the invention are lead-free initiating agents or initiating agent mixtures and initiating and igniting compositions which contain the lead-free initiating agents or initiating agent mixtures.

The present invention relates to an organic electronic device comprising a semiconductor layer which comprises a compound of formula (1).

##STR00001##

The present invention relates to an organic electronic device comprising a semiconductor layer which comprises a compound of formula (1).

##STR00001##

Provided are powder of a pure disilver hydrogen citrate-containing composition in powder form, having excellent solubility, and a method for easily obtaining the disilver hydrogen citrate-containing composition with high efficiency. In addition, provided are an antibacterial agent or antiviral agent, containing the disilver hydrogen citrate-containing composition, and a method for producing the same.

The method for producing a disilver hydrogen citrate-containing composition of the present invention includes the following processes (1) to (3): (1) preparing a reaction mixture containing a silver compound and citric acid, the reaction mixture having a pH of 2.0 to 5.5; (2) precipitating the disilver hydrogen citrate-containing composition from the reaction mixture; and (3) collecting the precipitated disilver hydrogen citrate-containing composition.

A metal-organic chalcogenolate (MOC) includes silver phenylselenolate functionalized with at least one functional group. The functional group may be methyl (CH.sub.3), dimethylamine (N(CH.sub.3).sub.2), thiomethyl (SCH.sub.3), fluoro (F) trifluoromethyl (CF.sub.3), cyanide (CN), carboxy (COOH), nitrito (NO.sub.2), or alkoxy (OC.sub.xH.sub.y). The MOC can be in the form of a single crystal consisting essentially of a nanocluster (0D), a nanotube (1D), or a single monolayer (2D).

A metal-organic chalcogenolate (MOC) includes silver phenylselenolate functionalized with at least one functional group. The functional group may be methyl (CH.sub.3), dimethylamine (N(CH.sub.3).sub.2), thiomethyl (SCH.sub.3), fluoro (F) trifluoromethyl (CF.sub.3), cyanide (CN), carboxy (COOH), nitrito (NO.sub.2), or alkoxy (OC.sub.xH.sub.y). The MOC can be in the form of a single crystal consisting essentially of a nanocluster (0D), a nanotube (1D), or a single monolayer (2D).

An organometallic compound is represented by Formula 1 and an organic light-emitting device includes the same. The organic light-emitting device includes: a first; a second electrode facing the first electrode; and an organic layer between the first electrode and the second electrode and including an emission layer, wherein the organic layer includes an organometallic compound represented by Formula 1. ##STR00001##